Pancreatic Cancer Research

ResearcherHospital de GaldakaoActive in the last 2 years

Fernando Garicano Goldaraz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8410-3255; OpenAlex author ID A5029768582. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2025: 1 paper, 1 trial

Papers 1

  1. Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarc… Co-author DOI 10.1177/17588359241309828↗

Trials 1

  1. TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) Principal investigator NCT07284277↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ángela Lamarca Lete · 1 shared trial, 2025 · strength 0.49
  2. Alberto Muñoz Llarena · 1 shared trial, 2025 · strength 0.49
  3. Patricia Seoane Couselo · 1 shared trial, 2025 · strength 0.49
  4. Mariano Ponz Sarvisé · 1 shared trial, 2025 · strength 0.49
  5. Ismael Ghanem · 1 shared paper, 2025 · strength 0.21
  6. Rafael Álvarez-Gallego · 1 shared paper, 2025 · strength 0.21
  7. Joaquina Martínez-Galán · 1 shared paper, 2025 · strength 0.21
  8. Roberto Pazo-Cid · 1 shared paper, 2025 · strength 0.21
  9. Antonio Cubillo · 1 shared paper, 2025 · strength 0.21
  10. Teresa Mercade Macarulla · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.